USP29 and colorectal carcinoma: Expectedly, the depletion of USP29 effectively limited the proliferation of SW620 and HCT116 cells in vitro, and the xenograft tumor models revealed that USP29 downregulation inhibited the proliferation of CRC cells in vivo.